APPLICATION
NDA017691
TYPE
NDA
ORIGINAL APPROVAL
1976-04-15
LATEST ACTION
2001-10-03
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued
Products
DIPROSONEDiscontinued
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · OINTMENT · TOPICAL
Approval history
1998-12-07Manufacturing (CMC) · Supplement 22 · standardAP
1998-11-10Manufacturing (CMC) · Supplement 23 · standardAP
1998-07-31Manufacturing (CMC) · Supplement 21 · standardAP
1998-06-15Manufacturing (CMC) · Supplement 20 · standardAP
1990-08-01Manufacturing (CMC) · Supplement 17 · standardAP
1990-07-05Manufacturing (CMC) · Supplement 18 · standardAP
1986-09-12Manufacturing (CMC) · Supplement 16 · standardAP
1986-05-20Manufacturing (CMC) · Supplement 15 · standardAP
1984-06-01Manufacturing (CMC) · Supplement 13 · standardAP
1984-03-01Manufacturing (CMC) · Supplement 12 · standardAP
1982-07-21Efficacy · Supplement 10 · standardAP
1982-04-19Manufacturing (CMC) · Supplement 11 · standardAP
1981-09-02Manufacturing (CMC) · Supplement 9 · standardAP
1980-05-12Manufacturing (CMC) · Supplement 4 · standardAP
1979-12-26Labeling · Supplement 7 · standardAP
1979-08-29Manufacturing (CMC) · Supplement 6 · standardAP
1979-06-20Manufacturing (CMC) · Supplement 5 · standardAP
1979-01-02Labeling · Supplement 3 · standardAP
1977-09-06Manufacturing (CMC) · Supplement 2 · standardAP
1976-06-08Labeling · Supplement 1 · standardAP
1976-04-15Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.